[Carcinoid syndrome. Tryptophan metabolism--pathogenesis of concomitant symptoms--combination of tumours].
D000230:Adenocarcinoma / Q000150:complications; D007611:Aprotinin / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D002812:Chondroma / Q000150:complications; D003110:Colonic Neoplasms / Q000150:complications; D003533:Cyproheptadine / Q000627:therapeutic use; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D007414:Intestinal Neoplasms / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology* / Q000652:urine; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008487:Medical History Taking; D008784:Methysergide / Q000627:therapeutic use; D009362:Neoplasm Metastasis
D003533:Cyproheptadine; D006897:Hydroxyindoleacetic Acid; D007611:Aprotinin; D008784:Methysergide
Karzinoid-Syndrom. Tryptophan-Stoffwechsel--Pathogenese der Begleitsymptome--Tumorkombination.